IDEXX Laboratories Analyst Price Targets

Wall Street analyst price targets and consensus rating for IDEXX Laboratories (IDXX).

Price Target Range — 13 Quarters

Analyst Consensus — 11 Analysts

7Buy

4Hold

Consensus RatingNeutral# Analysts11Avg. Consensus PT$673Upside to Avg. PT+20.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 16, 2026	JP Morgan	Chris Schott	PT Cut	Overweight	$775→$750
Oct 12, 2026	Keybanc	Steve Dechert	Initiate	Sector Weight	—
Aug 11, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$800→$710
Aug 5, 2026	UBS	Andrea Alfonso	PT Raise	Neutral	$620→$670
Aug 5, 2026	Citigroup	Daniel Grosslight	PT Raise	Neutral	$650→$670
Jul 27, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$640→$620
Apr 28, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$730→$640
Apr 15, 2026	Citigroup	Daniel Grosslight	Initiate	Neutral	$650
Mar 31, 2026	Stifel	Jonathan Block	PT Cut	Buy	$775→$675
Feb 9, 2026	Piper Sandler	David Westenberg	PT Cut	Neutral	$775→$750
Feb 5, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$850→$800
Feb 3, 2026	UBS	Andrea Alfonso	PT Cut	Neutral	$750→$730
Feb 3, 2026	BTIG	Mark Massaro	PT Cut	Buy	$830→$800
Dec 9, 2025	Barclays	Glen Santangelo	Initiate	Overweight	$850
Nov 4, 2025	Morgan Stanley	Erin Wright	PT Raise	Overweight	$765→$805
Nov 4, 2025	UBS	Andrea Alfonso	PT Raise	Neutral	$710→$750
Nov 4, 2025	JP Morgan	Chris Schott	PT Raise	Overweight	$675→$775
Nov 4, 2025	BTIG	Mark Massaro	PT Raise	Buy	$785→$830
Oct 31, 2025	Stifel	Jonathan Block	Upgrade	Hold→Buy	$640→$700
Oct 1, 2025	UBS	Andrea Alfonso	Initiate	Neutral	$720

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.

Benzinga Newsdesk

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Analysts initiated coverage on ASBH, QNRX, AXGN and HOOD with bullish ratings and targets; IDXX received a Sector Weight rating.

Avi Kapoor

PRO
Keybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating

Keybanc analyst Steve Dechert initiates coverage on IDEXX Laboratories (NASDAQ:IDXX) with a Sector Weight rating.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710

Barclays analyst Glen Santangelo maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $800 to $710.

Benzinga Newsdesk

PRO
UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

UBS analyst Andrea Alfonso maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $620 to $670.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

Citigroup analyst Daniel Grosslight maintains IDEXX Laboratories (NASDAQ:IDXX) with a Neutral and raises the price target from $650 to $670.

Benzinga Newsdesk

IDEXX Laboratories Inc

IDEXX Laboratories Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
Keybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating

PRO
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710

PRO
UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

PRO
Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

People Also Watch

People Also Watch

IDEXX Laboratories Inc

IDEXX Laboratories Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROKeybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating

PROBarclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710

PROUBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

PROCitigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

PRO
Keybanc Initiates Coverage On IDEXX Laboratories with Sector Weight Rating

PRO
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $710

PRO
UBS Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670

PRO
Citigroup Maintains Neutral on IDEXX Laboratories, Raises Price Target to $670